“🩸 Comprehensive Lab Precautions for Chemotherapy, Targeted Therapy, and Immunotherapy in Hematology 🔬💊
General Labs Before Starting Any Therapy
1️⃣ CBC (Complete Blood Count):
•Neutrophils: ANC >1,500/μL (acceptable for most therapies; some allow ANC >1,000/μL).
•Platelets: >100,000/μL for intensive regimens; >50,000/μL for lower intensity.
•Hemoglobin: No absolute cutoff, but consider transfusion if Hb <8 g/dL for symptomatic patients.
2️⃣ Renal Function:
•Creatinine: Must be within institutional limits (often <1.5 mg/dL).
•eGFR or CrCl:
•Cisplatin: Avoid if CrCl <60 mL/min.
•Methotrexate: Hold if CrCl <60 mL/min for high-dose regimens.
•Lenalidomide: Adjust dose for CrCl <50 mL/min.
3️⃣ Liver Function Tests (LFTs):
•AST/ALT: Typically <2.5x ULN; hold most drugs if >5x ULN.
•Bilirubin:
•Vincristine: Reduce dose if bilirubin >1.5 mg/dL, hold if >3 mg/dL.
•Anthracyclines: Avoid if bilirubin >3 mg/dL.
4️⃣ Baseline Cardiac Function:
•LVEF: Should be >50% for anthracyclines and certain targeted therapies.
5️⃣ Coagulation Profile:
•PT/INR, aPTT, fibrinogen, and antithrombin III.
•Required for drugs like asparaginase and in patients at risk of thrombosis or bleeding.
6️⃣ Disease-Specific Labs:
•Acute leukemia: Uric acid, phosphate, LDH for TLS risk.
•CLL: Direct antiglobulin test (DAT) if hemolysis is suspected with fludarabine.
Chemotherapy Drugs and Their Precautions
1️⃣ Cisplatin (Nephrotoxic):
•Labs: Renal function (Cr, Mg, K).
•Cutoffs to Proceed: CrCl >60 mL/min, normal Mg/K levels.
•Precautions: Pre- and post-hydration with saline; monitor electrolytes.
2️⃣ Cyclophosphamide (Hemorrhagic Cystitis):
•Labs: CBC, renal function, urinalysis for hematuria.
•Cutoffs to Proceed: Platelets >50,000/μL, no gross hematuria.
•Precautions: Use mesna for high-dose regimens; ensure adequate hydration.
3️⃣ Methotrexate (Renal Hepatic):
•Labs: CBC, renal function, AST/ALT, bilirubin, urine pH (>7).
•Cutoffs to Proceed: CrCl >60 mL/min, bilirubin <3 mg/dL, AST/ALT <5x ULN.
•Precautions: Leucovorin rescue for high-dose therapy; alkalinize urine to prevent nephrotoxicity.
4️⃣ Vincristine (Neurotoxic):
•Labs: LFTs (bilirubin).
•Cutoffs to Proceed: Bilirubin <1.5 mg/dL; reduce dose by 50% if bilirubin 1.5–3 mg/dL.
•Precautions: Avoid intrathecal administration (fatal).
5️⃣ Anthracyclines (Doxorubicin, Daunorubicin):
•Labs: CBC, LFTs, echocardiogram (LVEF).
•Cutoffs to Proceed: LVEF >50%, bilirubin <3 mg/dL.
•Precautions: Avoid cumulative dose >450 mg/m² to prevent cardiotoxicity.
6️⃣ Asparaginase (Pegaspargase):
•Labs: Fibrinogen (>100 mg/dL), antithrombin III (>70%), LFTs, lipase/amylase.
•Cutoffs to Proceed: Normal fibrinogen and ATIII; hold if lipase >2x ULN.
•Precautions: Replace fibrinogen/ATIII if low; stop if pancreatitis occurs.
Monoclonal Antibodies (mAbs) and Precautions
1️⃣ Rituximab (anti-CD20):
•Labs: HBV panel, CBC, renal function.
•Cutoffs to Proceed: HBV prophylaxis in carriers; ANC >1,000/μL.
•Precautions: Premedicate with acetaminophen, antihistamines, and steroids.
2️⃣ Brentuximab Vedotin (anti-CD30):
•Labs: CBC, LFTs.
•Cutoffs to Proceed: Platelets >50,000/μL; bilirubin <1.5 mg/dL.
•Precautions: Monitor for peripheral neuropathy; adjust for hepatic impairment.
3️⃣ Daratumumab (anti-CD38):
•Labs: CBC, renal function.
•Cutoffs to Proceed: ANC >1,000/μL, platelets >50,000/μL.
•Precautions: Premedicate for infusion reactions; ensure blood type compatibility.
Targeted Therapies and Precautions
1️⃣ Imatinib/Dasatinib (BCR-ABL inhibitors):
•Labs: CBC, LFTs, renal function.
•Cutoffs to Proceed: ANC >1,000/μL, platelets >50,000/μL.
•Precautions: Adjust dose for hepatic or renal dysfunction.
#Hematology #ChemoSafety #LabMonitoring #Immunotherapy”